Literature DB >> 16150515

Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter?

F Coenen1, J T B M Tolboom, H W Frijlink.   

Abstract

In this study 27 full scale production batches of influenza sub-unit vaccine were evaluated on their stability. The batches varied with respect to the strains they contained and regarding the presence of the preservative thiomersal in the solution. The stability study showed that haemagglutinin content was the most sensitive parameter. An increase in the storage temperature strongly increased the degradation rate of haemagglutinin. The degradation rate of the haemagglutinin differed for the different strains tested. However, statistical evaluation of the data obtained for the most sensitive strain tested showed that even exposure during a 2 week period of the vaccine to room temperature would not adversely affect the shelf life claim of the influenza subunit vaccine of 1 year in the refrigerator. Moreover, this study showed that the presence of thiomersal in the solution has no effect on the stability of the vaccine.

Mesh:

Substances:

Year:  2005        PMID: 16150515     DOI: 10.1016/j.vaccine.2005.07.081

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Authors:  Min-Chul Kim; Jeong Woo Lee; Hyo-Jick Choi; Yu-Na Lee; Hye Suk Hwang; Jongsang Lee; Cheol Kim; Jong Seok Lee; Carlo Montemagno; Mark R Prausnitz; Sang-Moo Kang
Journal:  J Control Release       Date:  2015-05-21       Impact factor: 9.776

2.  Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

3.  Stability of Inactivated Influenza Vaccine in Polypropylene Syringes under Various Storage Conditions.

Authors:  Najla Tabbara; Martha Brown; Allison McGeer; Andrew Wyllie
Journal:  Can J Hosp Pharm       Date:  2019-12-01

4.  Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine.

Authors:  Senthil Murugappan; Harshad P Patil; Henderik W Frijlink; Anke Huckriede; Wouter L J Hinrichs
Journal:  AAPS J       Date:  2014-01-31       Impact factor: 4.009

5.  Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.

Authors:  Lauren Byrd-Leotis; Summer E Galloway; Evangeline Agbogu; David A Steinhauer
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  Limited Tryptic Digestion-Isotope Dilution Mass Spectrometry (LTD-IDMS): A Reagent-Free Analytical Assay To Quantify Hemagglutinin of A(H5N1) Vaccine Material.

Authors:  Hans C Cooper; Yuhong Xie; Giuseppe Palladino; John R Barr; Ethan C Settembre; Yingxia Wen; Tracie L Williams
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

7.  Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

Authors:  Felix Geeraedts; Vinay Saluja; Wouter ter Veer; Jean-Pierre Amorij; Henderik W Frijlink; Jan Wilschut; Wouter L J Hinrichs; Anke Huckriede
Journal:  AAPS J       Date:  2010-03-02       Impact factor: 4.009

Review 8.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

Review 9.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

10.  Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.

Authors:  Yoo Chun Kim; Jeong Woo Lee; E Stein Esser; Haripriya Kalluri; Jessica C Joyce; Richard W Compans; Ioanna Skountzou; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2021-02-15       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.